Aclidinium

Overview

Aclidinium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1194325).

API suppliers (1)

Suppliers of Aclidinium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Hovione FarmaCiencia SAPortugal

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Aclidinium expires 13 Mar 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(3R)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate

Canonical SMILES

C1C[N+]2(CCC1[C@H](C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5

InChIKey

ASMXXROZKSBQIH-VITNCHFBSA-N